opioid use

Receiving opioid use disorder-related telehealth services during the COVID-19 pandemic was associated with lower odds of overdose and better retention using medications like buprenorphine, according to a study published in JAMA Psychiatry.

The round brings the company's total raise to $83 million.

Flare Capital's Alexandra Mullin and Ian Chiang outline COVID-19's impact on the worsening opioid crisis and how the digital opioid use disorder space is likely to develop over the coming years.

The company formerly focused its efforts on enabling chronic pain management care.